ArticleStudies in mycology2011
Two new aflatoxin producing species, and an overview of Aspergillus section Flavi.
Article in Studies in mycology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
120 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Uncommon occurrence ratios of aflatoxin B1, B 2, G 1, and G 2 in maize and groundnuts from Malawi.Mycotoxin research · 2015Pooled it
- Diversity and toxigenic potential of Aspergillus section Flavi strains associated with maize and its main by-products in northern Côte d'Ivoire.Mycotoxin research · 2026Article
- Taxonomic re-identification and biotechnological potential of a Brazilian Aspergillus section Flavi collection: exploring kojic acid production.World journal of microbiology & biotechnology · 2026Article
- Mutations and Metabolic Factors Affecting Interaction of Toxigenic and AtoxigenicMicroorganisms · 2026Article
- Culturable mycota from Karst caves in Yunnan Province, China.IMA fungus · 2026Article
- Case Report: Neurological and pulmonary angiostrongylosis in a Ryukyu long-furred rat (Frontiers in parasitology · 2026Article
- Dereplication-Guided Isolation of 3‑ACS omega · 2025Article
- Article
- In Vitro Screening of the Antifungal and Antimycotoxin Effects of a Stilbenoids-Riche Grapevine Cane Extract onToxins · 2025Article
- Review
- Unraveling the Therapeutic Potential of Antifungal Metabolites ofIndian journal of microbiology · 2025Article
- Mycotoxin-free Aspergillus oryzae strain lineage for alternative and novel protein production at industrial scale.Applied microbiology and biotechnology · 2025Review
- Evaluation of two MALDI-TOF MS systems and extraction methods for identification of filamentous fungi recovered from clinical specimens.Journal of clinical microbiology · 2025Article
- Molecular identification and antifungal susceptibility testing ofAfrican journal of laboratory medicine · 2025Article
- Identification ofFrontiers in veterinary science · 2025Article
- Metabolic modelling uncovers the complex interplay between fungal probiotics, poultry microbiomes, and diet.Microbiome · 2024Article
- Recent progress, challenges, and future perspectives of electrochemical biosensing of aflatoxins.Mikrochimica acta · 2024Review
- What are the 100 most cited fungal genera?Studies in mycology · 2024Article
- Comprehensive Review of Aflatoxin and Ochratoxin A Dynamics: Emergence, Toxicological Impact, and Advanced Control Strategies.Foods (Basel, Switzerland) · 2024Review
- Characterization of Aspergillus section Flavi associated with stored grains.Mycotoxin research · 2024Article
60 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aspergillus subgenus Circumdati section Flavi includes species with usually biseriate conidial heads, in shades of yellow-green to brown, and dark sclerotia. Several species assigned to this section are either important mycotoxin producers including aflatoxins, cyclopiazonic acid, ochratoxins and kojic acid, or are used in oriental food fermentation processes and as hosts for heterologous gene expression. A polyphasic approach was applied using morphological characters, extrolite data and partial calmodulin, β-tubulin and ITS sequences to examine the evolutionary relationships within this section. The data indicate that Aspergillus section Flavi involves 22 species, which can be grouped into seven clades. Two new species, A. pseudocaelatus sp. nov. and A. pseudonomius sp. nov. have been discovered, and can be distinguished from other species in this section based on sequence data and extrolite profiles. Aspergillus pseudocaelatus is represented by a single isolate collected from Arachis burkartii leaf in Argentina, is closely related to the non-aflatoxin producing A. caelatus, and produces aflatoxins B & G, cyclopiazonic acid and kojic acid, while A. pseudonomius was isolated from insects and soil in the USA. This species is related to A. nomius, and produces aflatoxin B(1) (but not G-type aflatoxins), chrysogine and kojic acid. In order to prove the aflatoxin producing abilities of the isolates, phylogenetic analysis of three genes taking part in aflatoxin biosynthesis, including the transcriptional regulator aflR, norsolonic acid reductase and O-methyltransferase were also carried out. A detailed overview of the species accepted in Aspergillus section Flavi is presented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.